CD1A and Langerhans cell histiocytosis: We demonstrate that CD1a is not a unique marker for pathogenic LCs in LCH and a new definition to include CD3− and CD1a+ and/or CD207+ cells or the presence of Birbeck granules is required for the identification of pathogenic LCs in LCH.